Darmanara Products

Biotest is a company specializing in innovative products for hematology and immunology with the holistic approach of a global pharmaceutical, diagnostics, and biotherapeutics group. The most important raw material for our pharmaceutical products is human blood plasma, which we process into effective and highly pure drugs in one of the world’s most modern production facilities in Europe. Our products are used in the treatment of life-threatening diseases such as coagulation disorders (hemophilia), severe infections, or disorders of the immune system. Biotest’s products meet the highest standards and are sold in markets that must meet the most stringent regulatory requirements in the world. Patients, hospitals, physicians, laboratories, and companies in 70 countries around the globe rely on Biotest’s quality and safety.

Hepatect CP

Hepatect CP contains 50 mg/ml of human plasma protein consisting of at least 96% immunoglobulin G (IgG). The hepatitis B antibody content is 50 IU/ml. Hepatitis B is an inflammation of the liver caused by the hepatitis B virus.

Haemoctin

Haemoctin is a clotting factor VIII concentrate derived from blood plasma, used for the treatment and prevention of bleeding in patients with hemophilia A.

Pentaglobin

Pentaglobin is administered in severe bacterial infections in addition to antibiotic therapy. Early administration of Pentaglobin yields a significantly better result in patients with severe bacterial infections. contains up to 16 times higher titers against clinically relevant pathogens than a standard immunoglobulin preparation (see figure below).

Albiomin

Human albumin, a solution for infusion. Albiomin 5% (50 g/l) is a solution for intravenous infusion. One liter of the solution contains 50 g of human plasma protein, of which at least 96% is human albumin.

Zutectra

Human hepatitis B immunoglobulin The active substance is human hepatitis B immunoglobulin 500 IU/ml. Zutectra contains 150 mg/ml human plasma protein, of which at least 96% is immunoglobulin G (IgG).

Haemonine

Haemonine is prescribed to stop or prevent bleeding due to a deficiency of factor IX (hemophilia B) in the blood of adults, adolescents, and children aged 6 years and over.

Intratect

The active ingredient of Intratect is human immunoglobulin for intravenous administration. Intratect contains 50 g/l or 100 g/l of human normal immunoglobulin, of which at least 96 % is immunoglobulin G (IgG).

Founded in 2011, Nestlé Health Science is the first of a new breed of health science companies. Our goal is to advance the therapeutic role of nutrition and change the course of health management for consumers, patients, physicians, nurses, and healthcare partners alike. By investing in innovation and harnessing cutting-edge science, Nestlé Health Science aims to build a new nutritional therapies industry based on inherently safe nutritional therapies with relevant quality-of-life benefits and proven clinical and health economic value. Already today, Nestlé Health Science produces nearly one billion science-based nutritional solutions per year, either available in retail outlets and pharmacies or recommended by healthcare professionals in health centers. These solutions cover a spectrum of ages and health conditions – from pediatric allergies to malnutrition in the frail elderly.

Resource Junior

Resource Junior is a complete diet to support growth and weight gain in children 1-10 years of age.

Peptamen Junior

eptamen Junior is the proven peptide-based pediatric formula to promote absorption and tolerance. It helps dyspeptic children up to age 10 with incredible results.

Peptamen

Peptamen is the proven peptide-based formula designed to promote absorption and tolerance. Nutrition to support improved outcomes for critically ill patients that they are from 10 years onwards.

The OPTIFAST program is a comprehensive, medically supported, weight management program. It combines medical support, nutritionally complete meal replacement products, behavioral elements, and physical activity to help patients achieve lasting weight loss. The program uses a complete meal replacement plan that transitions into self-prepared “everyday” meals, along with comprehensive patient education and support. The Optifast® VLCD™ program is a nutritionally complete, very low-calorie diet designed for the management of obesity and severely overweight individuals. The product range includes Optifast® VLCD™ Shake, Optifast® VLCD™ Bar, Optifast® VLCD™ Dessert, and Optifast® VLCD™ Soup.

Chocolate shake

Optifast VLCD Chocolate Shake can be enjoyed with every meal as part of the Optifast program. It is high in protein, so you feel fuller for longer, and it is also low in calories. How to use: simply add one sachet of Optifast VLCD Chocolate Shake mix to 200ml-250ml of cold water.

Strawberry shake

Optifast VLCD Strawberry Shake can be enjoyed with every meal as part of the Optifast program. It is rich in protein, so you feel fuller for longer, and it is also low in calories.

Vanilla shake

Optifast VLCD Vanilla Shake can be enjoyed with every meal as part of the Optifast program. It is rich in protein, so you feel fuller for longer, and it is also low in calories.

Dessert Chocolate

How to use: simply add one sachet of Optifast VLCD Chocolate Dessert to 200ml of cold water and mix it vigorously with a whisk or fork. Leave it in the fridge for 5 minutes. Store it covered in the fridge (< 4 °C).

Chicken Soup

How to use: to prepare your Optifast VLCD Chicken Flavor Soup, simply add one sachet to 200ml-250ml of hot water. Stir it until the contents of the sachet are completely dissolved. Add more water if you prefer a larger portion or a diluted flavor.

Cappuccino Bar

How to use: Optifast bars are convenient and ready to eat. By the standards of the Optifast program, one bar is equivalent to one meal in terms of its nutritional value.

Products

One of the big pharmaceutical companies in the field of respiratory diseases and treatment options with biotechnology products which started its activities at the end of 2013 in Turkey. It has shaped its works with the principle of “Forward vision, safe treatment in Respiratory and Biotechnology”. ARVEN, together with Sanovel Pharmaceuticals, has taken its place within the TOKSOZ Group while aiming at becoming one of the most important institutions of the Turkish Pharmaceutical Industry with its strong and high production capacity in compliance with international standards in terms of its scientific and technological infrastructure as well as human resources. The company employs approximately 200 people with its production facility established in an area of 30.000 m2 in Kırklareli which started its operations in 2017 and R&D facilities established in Selimpaşa.